ZEB1 and cancer: In contrast, a significant inverse correlation was found between the expression of MIR200CHG and ZEB1, a core EMT marker, consistently across 20 cancers (Supplementary Fig. 11c), suggesting that the function of MIR200CHG in inhibiting the EMT pathway may represent a general mechanism to suppress cancer metastasis.